In a recent study, patients with early puberty had increased rates of diabetes, obesity, and other metabolic conditions, as well as increased mental health risks.
Early puberty is a significant risk factor for metabolic and mental disorders, according to a recent study published in Frontiers in Pediatrics.1
Data has indicated a rising prevalence of early puberty onset, which has been linked to multiple adverse health outcomes. However, there is still little information about overall risks associated with early puberty.
In a recent review, investigators summarized outcomes of early puberty at a population level. Links with metabolic diseases including cardiovascular disease (CVD), as well as hypertensive disorders such as gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM), were discussed.
Puberty onset will often occur in girls aged 8 to 13 years and boys aged 9 to 14 years. However, certain developments have begun to occur earlier over the previous century, such as a 3-month decrease in the onset of breast development. Similarly, the average ages when girls experience pubarche and menarche have decreased.
Early puberty trends have also been reported in boys. These include earlier ages of Tanner stage G2 of genital development and voice breaking.
An increase in early puberty rates was also reported during the COVID-19 pandemic.2 One study reported a rapidly progressive idiopathic central precocious puberty rate of 1.44 cases per month from January 2016 to February 2020, vs 3.8 cases per month from March 2020 to June 2021.
The review included studies about pubertal markers to evaluate metabolic and mental impacts.1 According to investigators, thelarche, defined as breast development, is the gold standard for predicting puberty onset in girls. However, self-reported menarche is the most commonly used marker and is at risk of reporting bias.
Puberty is associated with a rapid increase in insulin resistance, leading to increased risks of developing metabolic disease such as T2DM. Patients with early puberty are at an increased risk of metabolic diseases such as diabetes and CVD.
Hormonal changes during puberty may also lead to weight gain, increasing obesity risk. According to the World Health Organization, approximately 1 in 3 school-aged children in Europe were impacted by overweight or obesity in 2022, highlighting its status as a major public health concern.
The relationship between obesity and early puberty is bidirectional, meaning the onset of one increases the risk of the other. Additionally, the link between early puberty and obesity risk later in life is more pronounced in girls than in boys. One study reported an increased body mass index (BMI) of 0.34 kg/m2 among girls with early menarche.
Diabetes, reported as the ninth leading cause of death worldwide in 2018, is also more likely in patients with early puberty. Data has indicated early puberty as an independent risk factor for GDM and T2DM, with a later age at menarche linked to a relative risk of 0.91 per year.
An increased prevalence of T2DM was also found in girls with an earlier age at menarche vs boys with an earlier age at voice breaking, with an odds ratio of 1.24. Additionally, a negative association has been identified for age at menarche and metabolic markers of T2DM such as insulin, HOMA-IR and HOMA-β.
CVD, the leading cause of death worldwide, is more common in patients with overweight or obesity, diabetes, and high cholesterol levels. Data has indicated an association between early puberty and CVD even after adjusting for age and BMI, with a hazard ratio of 1.22 for stroke and 1.16 for coronary heart disease.
Early puberty has also been linked to mental disorders because of rapid physical maturation alongside gradual phycological development. Hormonal fluctuations, social and emotional maturation, and stressful situations all may contribute to these conditions.
This data highlights significant metabolic and mental health outcomes among patients with early puberty. Investigators recommended establishing a gold standard to enhance the specificity of early puberty research.
References
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More